Medical Education Library

CALCITRIOL OINTMENT: A New Option for Topical Psoriasis Therapy


A supplement to Skin & Allergy News. This supplement was supported by Galderma.

Topic Highlights
Faculty/Faculty Disclosures

To view the supplement, click the image above.
Topic Highlights

• Topical Vitamin D3: A Mainstay in Psoriasis Care
• Calcitriol 3 ug/g Ointment: A Unique Option for Psoriasis Treatment
• Calcitriol Ointment Long-Term Study: Safety and Efficacy for Up to 52 Weeks
• Calcitriol Ointment: Use in Psoriasis Treatment Regimens
• Surgical Therapies
• Summary
Faculty/Faculty Disclosures

Emily Becker, MD
Clinical Research Fellow
Department of Dermatology
University of California, San Francisco
Dr. Becker has nothing to disclose.

John Y.M. Koo, MD, PhD
Department of Dermatology
University of California, San Francisco
Director, UCSF Psoriasis Treatment Center
Dr. Koo is a consultant to Abbott Laboratories, Amgen, Inc., Astellas Pharma US, Inc., Galderma Laboratories, L.P., Stiefel Laboratories, Inc., Photomedix, Inc., Novartis Pharmaceuticals Corporation, and Warner-Chilcott. He has received grant/research support from Abbott, Amgen, Astellas, Galderma, Photomedix, Ranbaxy Pharmaceuticals, Inc., Teikoku Pharma USA, Inc., and Warner-Chilcott. He also served on the speaker's bureau of Abbott, Amgen, Astellas, Galderma, and Warner-Chilcott.

Copyright © 2009 by Elsevier Inc.

Next Article: